维普中文期刊产品整合服务
19篇 您的检索式:作者名="Gathof"
    题名 作者 年代 出处 被引量
1Atorvastatin,gold standard for prophylaxis of myocardial ischemia and stroke-comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies显示文摘Gresser Gathof 2004Eur-J-Med-Res2004,9,1:1
2Epidemiology, etiology and diagnosis of venous thrombosis显示文摘Gathof BS Picker SM Rojo J 2004Eur J Med Res2004,9,3:1
3Developing an infrastructure for the naval oceanographic office survey operations center 显示文摘Gathof J M Bassich J B 2002Oceans Conference Record2002,,4:1
4Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-Hcl for pathogen inactlvation 显示文摘Picker SM Speer R Gathof BS 2004Transfusion2004,44,3:1
5Benzbromarone and fenofibrateare lipid lowering and uricosuric: a possible key to metabolic syn-drome? 显示文摘Gresser U Gathof BS and Gross M 1994Adv Exp Med Biol1994,370,:1
6Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets~ Results of a three-arm in vitro study 显示文摘Picker SM Steisel A Gathof BS 2009Transfus Apher Sci2009,40,2:1
7Developing an infrastructure for the naval oceanographic office survey operations center显示文摘Gathof J M Bassich J B 2002Oceans Conference Record2002,,4:1
8Platelet function assessed by shear induced deposition of split triple dose apheresis concentrates treated with pathogen reduction technologies 显示文摘Picker SM Schneider V Gathof BS 2009Transfusion2009,49,12:1
9Atorvastatin:gold standard for prophylaxis of myocardial ischemia and atrokecomparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies显示文摘Greaser U Gathof B S 0,,:1
10Epidemiology , etiology and diagnosis of venous thrombosis显示文摘 Picker SM Rojo J 2004Eur J Med Res2004,9,3:1
11Atorvastatin: gold standard for prophylaxis of myocardial and strok-comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies 显示文摘Gresser U Gathof BS 2004Eur J Med Res2004,9,1:1
12Atorvastatin:gold standard for prophylaxis of myocardial ischemia and stroke-comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies显示文摘Gresser U Gathof BS 2004Eur J Med Res2004,9,1:1
13Functional characteristics of huffy-coat PLTs photochemically treated with amotosalen Hcl for pathogen inactivation显示文摘Picker SM Speer R Gathof BS 2004Tranfusion2004,44,3:1
14Atorvastatin:gold standard for prophylaxis of myocardial ischemia and stroke-comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies显示文摘Gresser U Gathof BS 2004EurJ Med Res2004,9,:1
15Functional characteristics of buf- fy-coat PLTs photochemically treated with amotosalen-HC1 for pathogen inactivation 显示文摘Picker SM Specr R Gathof BS 2004Transfusion2004,44,3:1
16Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke-comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies显示文摘GresserU Gathof BS 2004Eur J Med Res2004,9,1:1
17Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies显示文摘Gresser U Gathof BS 2004Eur J Med Res2004,9,1:1
18A Prospective Crossover Trial Comparing Performance and in vitro Platelet Quality of Three New Apheresis Devices with Current Equipment 显示文摘PICKER S M RADOJSKA S M GATHOF B 5 2006Transfus Med Hemother2006,33,:1
19Atorvastatin : gold standard for prophylaxis of myocardi- al ischemia and stroke-comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies 显示文摘Gresser U Gathof BS 2004Eur J Med Res2004,9,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费